Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma

References

• Papiez L, Timmerman R, DesRosiers C, Randall M. Extracranial stereotactic radioablation: Physical principles. Acta Oncol 2003;42:882–94.
   PubMed Web of Science ®Google Scholar
• Potters L, Steinberg M, Rose C, Timmerman R, Ryu S, Hevezi JM, . American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2004; 60:1026–32.
   PubMed Web of Science ®Google Scholar
• Baumann P, Nyman J, Lax I, Friesland S, Hoyer M, Rehn Ericsson S, . Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006;45:787–95.
   Google Scholar
• Dunlap NE, Cai J, Biedermann GB, Yang W, Benedict SH, Sheng K, . Chest wall volume receiving > 30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010;76: 796–801.
   PubMed Web of Science ®Google Scholar
• Fritz P, Kraus HJ, Blaschke T, Muhlnickel W, Strauch K, Engel-Riedel W, . Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning. Lung Cancer 2008;60:193–9.
   PubMed Web of Science ®Google Scholar
• Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;70:685–92.
   PubMed Web of Science ®Google Scholar
• Meric F, Buchholz TA, Mirza NQ, Vlastos G, Ames FC, Ross MI, . Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 2002;9:543–9.
   PubMed Web of Science ®Google Scholar
• Pettersson N, Nyman J, Johansson KA. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: A dose- and volume-response analysis. Radiother Oncol 2009;91:360–8.
   PubMed Web of Science ®Google Scholar
• Stotter AT, McNeese MD, Ames FC, Oswald MJ, Ellerbroek NA. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer 1989;64:2217–25.
   PubMed Web of Science ®Google Scholar
• Voroney JP, Hope A, Dahele MR, Purdie TG, Franks KN, Pearson S, . Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer. J Thorac Oncol 2009;4:1035–7.
   PubMed Web of Science ®Google Scholar
• Zimmermann FB, Geinitz H, Schill S, Thamm R, Nieder C, Schratzenstaller U, . Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 2006;45:796–801.
   PubMed Web of Science ®Google Scholar
• Nirula R, Mayberry JC. Rib fracture fixation: Controversies and technical challenges. Am Surg 2010;76:793–802.
   PubMed Web of Science ®Google Scholar
• Bush DA, Hillebrand DJ, Slater JM, Slater JD. High-dose proton beam radiotherapy of hepatocellular carcinoma: Preliminary results of a phase II trial. Gastroenterology 2004;127:S189–93.
   Web of Science ®Google Scholar
• Chiba T, Tokuuye K, Matsuzaki Y, Sugahara S, Chuganji Y, Kagei K, . Proton beam therapy for hepatocellular carcinoma: A retrospective review of 162 patients. Clin Cancer Res 2005;11:3799–805.
   PubMed Web of Science ®Google Scholar
• Fukumitsu N, Sugahara S, Nakayama H, Fukuda K, Mizumoto M, Abei M, . A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2009; 74:831–6.
   PubMed Web of Science ®Google Scholar
• Mizumoto M, Okumura T, Hashimoto T, Fukuda K, Ochiro Y, Fukumitsu N, . Proton beam therapy for hepatocellular carcinoma: A comparison of three treatment protocols. Int J Radiat Oncol Biol Phys 2011;81:1039–45.
   PubMed Web of Science ®Google Scholar
• Bush DA, Kayali Z, Grove R, Slater JD. The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: A phase 2 prospective trial. Cancer 2011; 117:3053–9.
   PubMed Web of Science ®Google Scholar
• Kawashima M, Kohno R, Nakachi K, Nishio T, Mitsunaga S, Ikeda M, . Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2011; 79:1479–86.
   PubMed Web of Science ®Google Scholar
• Mizumoto M, Tokuuye K, Sugahara S, Nakayama H, Fukumitsu N, Ohara K, . Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis. Int J Radiat Oncol Biol Phys 2008;71:462–7.
   PubMed Web of Science ®Google Scholar
• Paganetti H, Niemierko A, Ancukiewicz M, Gerweck LE, Goitein M, Loeffler JS, . Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 2002;53:407–21.
   PubMed Web of Science ®Google Scholar
• Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679–94.
   PubMed Web of Science ®Google Scholar
• Tsunashima Y, Sakae T, Shioyama Y, Kagei K, Terunuma T, Nohtomi A, . Correlation between the respiratory waveform measured using a respiratory sensor and 3D tumor motion in gated radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:951–8.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–81.
   Web of Science ®Google Scholar
• Akobeng AK. Understanding diagnostic tests 3: Receiver operating characteristic curves. Acta Paediatr 2007;96:644–7.
   PubMed Web of Science ®Google Scholar
• Kozak KR, Smith BL, Adams J, Kornmehl E, Katz A, Gradd M, . Accelerated partial-breast irradiation using proton beams: Initial clinical experience. Int J Radiat Oncol Biol Phys 2006;66:691–8.
   PubMed Web of Science ®Google Scholar